Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 18195377)

Published in Radiology on January 14, 2008


Mari Hagiwara1, Henry Rusinek, Vivian S Lee, Mariela Losada, Michael A Bannan, Glenn A Krinsky, Bachir Taouli

Author Affiliations

1: Department of Radiology, New York University Medical Center, 560 First Ave, New York, NY 10016, USA.

Associated clinical trials:

Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium | NCT01783314

Articles citing this

Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol (2010) 3.30

Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging (2010) 1.96

Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59

Perfusion magnetic resonance imaging of the liver. World J Gastroenterol (2010) 1.40

Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39

How Can New Imaging Modalities Help in the Practice of Radiology? Eurasian J Med (2016) 1.18

Parametric exploration of the liver by magnetic resonance methods. Eur Radiol (2009) 1.05

Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol (2011) 1.02

Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol (2011) 1.02

Quantitative liver MRI combining phase contrast imaging, elastography, and DWI: assessment of reproducibility and postprandial effect at 3.0 T. PLoS One (2014) 1.02

Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. World J Gastroenterol (2013) 0.97

Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases. World J Gastroenterol (2012) 0.95

Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology (2014) 0.93

A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol (2012) 0.92

Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol (2014) 0.89

High-spatial and high-temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved three-dimensional radial MRI. Magn Reson Med (2014) 0.88

DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility. J Magn Reson Imaging (2013) 0.88

Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI. AJR Am J Roentgenol (2013) 0.88

Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection. Liver Int (2016) 0.85

DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker. World J Gastroenterol (2014) 0.85

Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol (2015) 0.84

Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction. Invest Radiol (2015) 0.84

Noninvasive diagnosis of cirrhosis: a review of different imaging modalities. World J Gastroenterol (2014) 0.83

Multiparametric MR Imaging in Abdominal Malignancies. Magn Reson Imaging Clin N Am (2016) 0.83

MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide. Eur Radiol (2010) 0.81

Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Sci Rep (2015) 0.81

The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach. Eur Radiol (2015) 0.80

Liver diffusivity in healthy volunteers and patients with chronic liver disease: comparison of breathhold and free-breathing techniques. J Magn Reson Imaging (2011) 0.80

DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection. PLoS One (2014) 0.80

Quantitative hepatic perfusion modeling using DCE-MRI with sequential breathholds. J Magn Reson Imaging (2013) 0.78

Vascular assessment of liver disease-towards a new frontier in MRI. Br J Radiol (2016) 0.78

Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention. Eur Radiol (2013) 0.78

Spectral CT: preliminary studies in the liver cirrhosis. Korean J Radiol (2012) 0.77

Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases. BMC Gastroenterol (2013) 0.76

Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI? J Magn Reson Imaging (2016) 0.76

Free-breathing liver perfusion imaging using 3-dimensional through-time spiral generalized autocalibrating partially parallel acquisition acceleration. Invest Radiol (2015) 0.76

Assessment of liver fibrosis in the early stages with perfusion CT. Int J Clin Exp Med (2015) 0.75

GPU-accelerated voxelwise hepatic perfusion quantification. Phys Med Biol (2012) 0.75

Liver lobe-based magnetic resonance diffusion-weighted imaging using multiple b values in patients with hepatitis B-related liver cirrhosis: association with the liver disease severity according to the Child-Pugh class. Clinics (Sao Paulo) (2015) 0.75

Enabling 3D-Liver Perfusion Mapping from MR-DCE Imaging Using Distributed Computing. J Med Eng (2013) 0.75

Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging. EJNMMI Res (2015) 0.75

Estimation of contrast agent bolus arrival delays for improved reproducibility of liver DCE MRI. Phys Med Biol (2016) 0.75

Liver Apparent Diffusion Coefficient Changes during Telaprevir-Based Therapy for Chronic Hepatitis C. Balkan Med J (2016) 0.75

The evaluation of haemodynamics in cirrhotic patients with spectral CT. Br J Radiol (2013) 0.75

Feasibility of histogram analysis of susceptibility-weighted MRI for staging of liver fibrosis. Diagn Interv Radiol (2016) 0.75

DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model-initial experience. MAGMA (2015) 0.75

MR imaging in liver cirrhosis: classical and new approaches. Insights Imaging (2010) 0.75

Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis. Sci Rep (2017) 0.75

Diminished liver microperfusion in Fontan patients: A biexponential DWI study. PLoS One (2017) 0.75

Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers. Invest Radiol (2017) 0.75

Recent advances in molecular magnetic resonance imaging of liver fibrosis. Biomed Res Int (2015) 0.75

Validation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging. Ultrasound Med Biol (2017) 0.75

Arterial and portal venous liver perfusion using selective spin labelling MRI. Eur Radiol (2015) 0.75

Articles by these authors

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44

Nonenhanced MR angiography. Radiology (2008) 2.77

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology (2008) 2.34

Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology (2015) 2.11

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 2.04

Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol (2007) 2.02

Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging (2010) 1.96

Perfusion imaging of the liver: current challenges and future goals. Radiology (2005) 1.95

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology (2009) 1.94

Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging (2007) 1.90

Small pulmonary nodules: volume measurement at chest CT--phantom study. Radiology (2003) 1.73

Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol (2011) 1.72

Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging (2010) 1.70

Kidney function: glomerular filtration rate measurement with MR renography in patients with cirrhosis. Radiology (2011) 1.66

Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol (2013) 1.65

Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology (2004) 1.61

Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59

Wavelet compression of low-dose chest CT data: effect on lung nodule detection. Radiology (2003) 1.58

Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur J Radiol (2012) 1.58

Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. AJNR Am J Neuroradiol (2005) 1.56

Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging (2009) 1.50

Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50

MRI of female urethral and periurethral disorders. AJR Am J Roentgenol (2004) 1.47

Accelerated phase-contrast cine MRI using k-t SPARSE-SENSE. Magn Reson Med (2011) 1.45

Optimal k-space sampling for dynamic contrast-enhanced MRI with an application to MR renography. Magn Reson Med (2009) 1.42

Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol (2006) 1.41

Fully automatic segmentation of the brain from T1-weighted MRI using Bridge Burner algorithm. J Magn Reson Imaging (2008) 1.41

CT findings in acute gangrenous cholecystitis. AJR Am J Roentgenol (2002) 1.39

Comprehensive preoperative evaluation and repair of inguinal hernias at the time of open radical retropubic prostatectomy decreases risk of developing post-prostatectomy hernia. BJU Int (2012) 1.39

Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology (2010) 1.38

Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol (2011) 1.37

Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI. J Cereb Blood Flow Metab (2012) 1.36

The pathology of diverticulosis coli. J Clin Gastroenterol (2004) 1.36

Renal function measurements from MR renography and a simplified multicompartmental model. Am J Physiol Renal Physiol (2007) 1.35

Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging (2011) 1.34

Optimization of b-value sampling for diffusion-weighted imaging of the kidney. Magn Reson Med (2011) 1.32

Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters--a pilot study. Radiology (2012) 1.31

Cardiovascular applications of phase-contrast MRI. AJR Am J Roentgenol (2009) 1.30

Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology (2004) 1.27

3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging (2008) 1.27

Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. J Alzheimers Dis (2009) 1.26

Performance of an automated segmentation algorithm for 3D MR renography. Magn Reson Med (2007) 1.26

Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol (2009) 1.23

Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med (2003) 1.22

Intravoxel incoherent motion and diffusion-tensor imaging in renal tissue under hydration and furosemide flow challenges. Radiology (2012) 1.21

MR findings in knee osteoarthritis. Eur Radiol (2002) 1.21

Functional renal MR imaging. Magn Reson Imaging Clin N Am (2004) 1.18

Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. AJR Am J Roentgenol (2010) 1.18

Quantitative determination of Gd-DTPA concentration in T1-weighted MR renography studies. Magn Reson Med (2007) 1.18

Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology (2012) 1.12

Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examination. AJNR Am J Neuroradiol (2002) 1.12

Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging (2013) 1.11

Functional assessment of the kidney from magnetic resonance and computed tomography renography: impulse retention approach to a multicompartment model. Magn Reson Med (2008) 1.11

Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol (2010) 1.11

Renal functional MRI: Are we ready for clinical application? AJR Am J Roentgenol (2009) 1.09

Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol (2002) 1.08

What causes diminished corticomedullary differentiation in renal insufficiency? J Magn Reson Imaging (2007) 1.07

Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology (2006) 1.07

MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults. Invest Radiol (2012) 1.05

T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology (2009) 1.05

Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol (2012) 1.05

Dynamic three-dimensional MR renography for the measurement of single kidney function: initial experience. Radiology (2003) 1.04

Celiac artery compression by the median arcuate ligament: a pitfall of end-expiratory MR imaging. Radiology (2003) 1.04

Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients. Hepatology (2012) 1.03

Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. J Magn Reson Imaging (2014) 1.02

Tailoring the flow sensitivity of fast spin-echo sequences for noncontrast peripheral MR angiography. Magn Reson Med (2010) 1.01

Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms. Psychiatry Res (2002) 1.01

Pulmonary Nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry. Radiology (2011) 1.01

Perspectives on body MR imaging at ultrahigh field. Magn Reson Imaging Clin N Am (2007) 1.00

Subclavian steal syndrome: diagnosis with perfusion metrics from contrast-enhanced MR angiographic bolus-timing examination--initial experience. Radiology (2005) 0.99

Characterization of malignancy of adnexal lesions using ADC entropy: comparison with mean ADC and qualitative DWI assessment. J Magn Reson Imaging (2012) 0.99

Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience. Radiology (2004) 0.98

Time-resolved dynamic contrast-enhanced MR urography for the evaluation of ureteral peristalsis: initial experience. J Magn Reson Imaging (2008) 0.98

Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction. J Magn Reson Imaging (2010) 0.98

Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cereb Blood Flow Metab (2010) 0.97

Focal amyloidoma of the small bowel mimicking adenocarcinoma on CT. AJR Am J Roentgenol (2005) 0.97

Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy. J Magn Reson Imaging (2014) 0.97

Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl (2002) 0.97

MRI of pelvic floor dysfunction: dynamic true fast imaging with steady-state precession versus HASTE. AJR Am J Roentgenol (2008) 0.96